Details of each partnership, as well as additional activities conducted by Medtronic, include the following:
- Health Equity Now Initiative with
ADA– Medtronic will provide a $1 millionsponsorship over the next three years to ADA’s Technology Access Project(TAP), which aims to provide access to and availability of diabetes technology regardless of gender, race, income, or location. TAP is a part of ADA’sHealth Equity Bill of Rights #9, which envisions a future for all people with diabetes to have equal rights to prioritize their health, and equal access to diabetes management resources and treatments.
“Health equity in diabetes is central to our mission, and unfortunately, for many the latest technological advancements to support living with the disease are not accessible due to insurance barriers and high out-of-pocket costs,” said
Charles D. Henderson, chief development officer, ADA. “We thank Medtronic for supporting our tireless work to break down obstacles to treatment, and hope that one day everyone with this disease has the opportunity to benefit from the important advancements that have been made in diabetes management.”
- Reducing Inequities in Diabetes Management with T1D Exchange – This partnership supports an upcoming quality improvement pilot to review data collected from in-person and telemedicine visits to determine baseline diabetes technology use rates among people of color (African Americans, Hispanic, and Asian) who tend to have lower adoption, and test interventions to determine their effects in technology adoption. Results will be used to develop and implement the ‘T1D Equity Framework’ with the goal of increasing education, fostering a shared decision approach, and improving adoption of diabetes technologies for people of color.
“As we continue to build the largest diabetes data platform in
the United States, partnerships with like-minded companies, such as Medtronic, allow us to use our data to better understand and improve quality of life for people living with this disease,” said Dave Walton, chief executive officer, T1D Exchange. “Patient education and access continue to drive the work we do, especially when it comes to ensuring people of color are receiving access to vital technology, resources and support.” Investigator-Initiated Research: “A Feasibility Study of Novel Combined Intervention for Blood Glucose Management in Type 1 Diabetes (T1D) Among African American Patients” – Medtronic is supporting this NIH-funded study by providing advanced hybrid closed loop insulin pump technology and training for the project. The study aims to improve glycemic control in high risk African Americanyouth with type 1 diabetes using Medtronic insulin pump technology, paired with frequent home telehealth visits conducted with a dedicated diabetes educator. The study is led by Dr. Stuart Chalewof the Department of Pediatricsat the Louisiana State University School of Medicineand the Children’s Hospital of New Orleans. The project will evaluate changes in mean blood glucose, HbA1c levels, glycemic variation, as well as quality of life and program adherence. Results are expected in 2022.
“Underlying barriers to health equity – including awareness, access, trust, bias and affordability – are unfortunate truths that exist in the
Every day more than 4,000 people are newly diagnosed with diabetes in America. More than 122 million Americans have diabetes or prediabetes and are striving to manage their lives while living with the disease. The
About T1D Exchange
T1D Exchange is a leader in harnessing data to advance type 1 diabetes (T1D) care and outcomes by driving collaborative change. Through real-world evidence and clinical data collection and analysis, its novel insights are identifying gaps in care and redefining best practices to improve the lives of those living with T1D. T1D Exchange actively supports quality improvement and innovation through its Quality Improvement Collaborative, patient registry, and data-oriented research services. Through a knowledge-sharing and collaboration-focused approach, T1D Exchange is accelerating real-world impacts by providing clinicians, researchers, industry partners and advocates with the resources and services they need for better decision support and population health management. A nonprofit organization, T1D Exchange was established in 2010 with ongoing support from
About the Diabetes Business at Medtronic (www.medtronicdiabetes.com)
Medtronic is working together with the global community to change the way people manage diabetes. The company aims to transform diabetes care by expanding access, integrating care and improving outcomes, so people living with diabetes can enjoy greater freedom and better health.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic reports on file with the
American Diabetes Association® is a registered trademark of
View original content to download multimedia:http://www.prnewswire.com/news-releases/medtronic-announces-ongoing-initiatives-to-address-health-equity-for-people-of-color-living-with-diabetes-301263702.html